TrialKey is an innovative AI and machine learning platform designed to revolutionise the clinical trial landscape by providing advanced optimisation and predictive capabilities. Tailored for Clinical Research Organisations (CROs) and pharmaceutical companies, TrialKey harnesses extensive datasets and sophisticated algorithms to enhance the design and execution of clinical trials, ultimately increasing the probability of success across all phases.
One of the key features of TrialKey is its TrialGen module, which enables precise trial design by offering recommendations on study type, sponsor selection, timelines, enrolment numbers, inclusion and exclusion criteria, and endpoint measures. The platform’s optimisation capabilities extend to refining intervention models, masking types, and resource allocation, ensuring trials are conducted efficiently and effectively. TrialKey's AI-driven analysis also reduces the need for costly amendments, accelerates market entry, and provides a competitive edge in the highly complex field of clinical research.
Beyond design optimisation, TrialKey excels in predictive analytics, offering over 90% accuracy in forecasting trial success. By simulating various trial scenarios and analysing competitor trials, the platform provides invaluable insights that guide strategic planning and decision-making. This includes benchmarking against similar trials, estimating success probabilities, and mapping out competitor activities by trial duration and completion dates.
TrialKey’s global applicability and scalability make it an essential tool for companies of all sizes, from small firms conducting a few trials annually to large organisations managing thousands. The platform supports a wide range of clinical trials, including those for drugs, medical devices, and alternative therapies, and is adaptable to diverse regulatory environments and clinical trial requirements worldwide. With a user-friendly design and comprehensive support services, TrialKey empowers clinicians, researchers, and investors to make informed decisions, optimise trial outcomes, and contribute to the advancement of medical research.